XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONVERTIBLE PROMISSORY NOTES AND SHORT TERM LOANS (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2021
Mar. 31, 2022
Dec. 21, 2021
Jan. 08, 2021
Obligation with Joint and Several Liability Arrangement [Line Items]            
Debt Instrument, Face Amount         $ 12,000,000  
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 1.06
Debt Issuance Costs, Net         $ 193,437  
Class of Warrant or Right, Outstanding     97,500 658,355    
Conversion Notice [Member]            
Obligation with Joint and Several Liability Arrangement [Line Items]            
Debt Conversion, Description The holder may exercise such conversion right by providing written notice to the Company of such exercise in a form reasonably acceptable to the Company (a “conversion notice”). Conversion price means (subject in all cases to proportionate adjustment for stock splits, stock dividends, and similar transactions), seventy-five percent (75%) multiplied by the average of the three (3) lowest closing prices during the previous ten (10) trading days prior to the receipt of the conversion notice          
Noteholders [Member]            
Obligation with Joint and Several Liability Arrangement [Line Items]            
Convertible Notes Payable $ 1,238,000          
Warrant [Member]            
Obligation with Joint and Several Liability Arrangement [Line Items]            
[custom:PlacementAgentFeesDescription] The Company was obligated to issue warrants that accompany the convertible notes and provide 50% warrant coverage. The warrants have a 3-year term from date of issuance and an exercise price that is 120% of the 20-day volume weighted average price of the Company’s common shares at the time final closing          
Warrant [Member] | Placement Agent [Member]            
Obligation with Joint and Several Liability Arrangement [Line Items]            
[custom:PlacementAgentFeesDescription] The Company was also obligated to issue warrants to the placement agent that have a 10-year term and cover 12% of funds raised for $8,925,550 (face value) of the notes (first series) and 2.5% of funds raised for the remaining $2,350,000 (face value) of notes (second series), with an exercise price that is 120% of the 20-day volume weighted average price of the Company’s common shares at the time final closing. On final closing, which occurred on January 8, 2021, the warrants’ exercise price was struck at $1.06 per share          
Series A Notes [Member]            
Obligation with Joint and Several Liability Arrangement [Line Items]            
Debt Instrument, Face Amount     $ 11,275,500 $ 700,000    
Debt Instrument, Interest Rate, Stated Percentage 12.00%          
Debt Conversion, Description the notes would automatically convert into common stock (in each case, subject to the trading volume of the Company’s common stock being a minimum of $500,000 for each trading day in the 20 consecutive trading days immediately preceding the conversion date), upon the earlier to occur of (i) the Company’s common stock being listed on a national securities exchange, in which event the conversion price would be equal to 75% of the volume weighted average price of the common stock for the 20 trading days prior to the conversion date, or (ii) upon the closing of the Company’s next equity round of financing for gross proceeds of greater than $5,000,000, in which event the conversion price would be equal to 75% of the price per share of the common stock (or of the conversion price in the event of the sale of securities convertible into common stock) sold in such financing. The Company could, at its discretion redeem the notes for 115% of their face value plus accrued interest          
Proceeds from Convertible Debt     10,135,690      
Debt Issuance Costs, Net $ 2,301,854          
Debt Instrument, Unamortized Discount       8,088,003    
Interest Payable $ 129,699          
Series A Notes [Member] | Placement Agent [Member]            
Obligation with Joint and Several Liability Arrangement [Line Items]            
[custom:PlacementAgentFeesDescription] The Company was obligated to pay the placement agent of the first series of Series A Notes a 12% cash fee for $8,925,550 (face value) of the notes and 2.5% cash fee and other sundry expenses for the remaining $2,350,000 (face value) of the notes          
Series A Notes Second [Member]            
Obligation with Joint and Several Liability Arrangement [Line Items]            
Debt Conversion, Description the notes would automatically convert into common stock (in each case, subject to the trading volume of the Company’s common stock being a minimum of $500,000 for each trading day in the 20 consecutive trading days immediately preceding the conversion date), upon the earlier to occur of (i) the Company’s common stock being listed on a national securities exchange, in which event the conversion price would be equal to the lower of $4.00 per share or 75% of the volume weighted average price of the common stock for the 20 trading days prior to the conversion date, or (ii) upon the closing of the Company’s next equity round of financing for gross proceeds of greater than $5,000,000, in which event the conversion price would be equal to the lower of $4.00 per share or 75% of the price per share of the common stock (or of the conversion price in the event of the sale of securities convertible into common stock) sold in such financing. The Company could, at its discretion redeem the notes for 115% of their face value plus accrued interest          
Sale of Stock, Price Per Share $ 4.00          
Series B Notes [Member]            
Obligation with Joint and Several Liability Arrangement [Line Items]            
Debt Instrument, Face Amount       840,000    
Debt Conversion, Description The Series B Notes will automatically convert into common stock upon a merger, consolidation, exchange of shares, recapitalization, reorganization, as a result of which the Company’s common stock shall be changed into another class or classes of stock of the Company or another entity, or in the case of the sale of all or substantially all of the assets of the Company other than a complete liquidation of the Company. Within the first 180 days after the issuance date, the Company may, at its discretion redeem the notes for 115% of their face value plus accrued interest. The Company is obligated to issue warrants that accompany the convertible notes and provide 50% warrant coverage          
Proceeds from Convertible Debt     1,240,000      
Debt Issuance Costs, Net       10,000    
Debt Instrument, Unamortized Discount       $ 1,312,500    
Interest Payable $ 74,550          
Debt Conversion, Converted Instrument, Amount $ 302,000          
Debt Conversion, Converted Instrument, Shares Issued 390,464          
Series B Notes [Member] | Accreditor Investors [Member]            
Obligation with Joint and Several Liability Arrangement [Line Items]            
Debt Instrument, Face Amount     $ 1,312,500      
Series B Notes [Member] | Warrant [Member]            
Obligation with Joint and Several Liability Arrangement [Line Items]            
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 1.06     $ 100,000    
Warrants and Rights Outstanding, Term 3 years          
Class of Warrant or Right, Outstanding 212,500          
Series B Notes [Member] | Warrant One [Member]            
Obligation with Joint and Several Liability Arrangement [Line Items]            
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 1.5          
General and Administrative Expense [Member]            
Obligation with Joint and Several Liability Arrangement [Line Items]            
Interest Expense $ 0 $ 56,220        
General and Administrative Expenses [Member]            
Obligation with Joint and Several Liability Arrangement [Line Items]            
Interest Expense, Debt $ 31,414 $ 265,658